Get started
Author

Mohammed Oukkal

Observed names: M Oukal, M Oukkal, M. Oukkal, Mohamed Oukkal
ORCID: 0000-0002-4306-8377
Observed ORCID: 0000-0002-4306-8377
OpenAlex ID: A5037735053
Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial
2023 · K. Alsaleh, H. Al Zahwahry, et al. · Journal of Cancer Research and Clinical Oncology · 19
PDF
Epidemiology of breast cancer in women based on diagnosis data from oncologists and senologists in Algeria
2020 · F Smaili, A Boudjella, et al. · Cancer Treatment and Research Communications · 12
PDF
Prediction of response to neoadjuvant hormonal therapy (NAHT) using upfront oncotype Dx recurrence score (RS): Results from the SAFIA phase III trial.
2020 · Khalid A Al-Saleh, Adda Bounedjar, et al. · Journal of Clinical Oncology · 11
Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay—Results From the SAFIA Phase III Trial
2021 · Khalid AlSaleh, Heba Al Zahwahry, et al. · JCO Global Oncology · 9
PDF
An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction
2021 · İrfan Cicin, Mohammed Oukkal, et al. · European Journal of Breast Health · 6
PDF
The first Middle East and North Africa expert consensus recommendations for the management of advanced colorectal cancer
2022 · Hampig R Kourie, Fahad Ibnshamsah, et al. · Future Oncology · 5
Incidence of lung cancer in males and females in Algeria: The lung cancer registry in Algeria (LuCaReAl)
2020 · Adda Bounedjar, Radjâa Benkali, et al. · Cancer Epidemiology · 5
Bevacizumab plus oxaliplatine, acide folinique et 5-fluoro-uracile (Folfox7) en première ligne de traitement des cancers colorectaux évolués et/ou métastatiques
2010 · M. Oukkal, K. Djilat, et al. · Bulletin du Cancer · 5
Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study
2022 · Asma‐Lamia Boumehdi, Farid Cherbal, et al. · Annals of Human Genetics · 4
Final result for SAFIA trial for neoadjuvant palbociclib in patients with operable luminal breast cancer responding to fulvestrant.
2022 · Khalid A. Al-Saleh, Heba Mohamed El Zawahry, et al. · Journal of Clinical Oncology · 4
Middle East and North Africa Registry to Characterize Rate of RAS Testing Status in Newly Diagnosed Patients with Metastatic Colorectal Cancer
2022 · Mohammed Oukkal, Kamel Bouzid, et al. · The Turkish Journal of Gastroenterology · 3
Utilisation d’une méthode d’analyse prospective des risques pour améliorer la sécurité du processus chimiothérapie anticancéreuse dans un service d’oncologie médicale en Algérie
2015 · S.O. Djermoune, M. Oukkal, et al. · Le Pharmacien Hospitalier et Clinicien · 3
An open-label, Multinational, Phase IIIb Study to Evaluate Patient and Satisfaction, Safety and Efficacy of Subcutaneous Administration of Trastuzumab in Patients With HER2-Positive Early Breast Cancer (ML28851) in Adjuvant/Neo-Adjuvant Setting
2018 · I. Ciçin, M. Oukkal, et al. · European Journal of Cancer · 2
Epidemiology of Extranodal Diffuse Large B Cell Lymphomas in Algeria: A Study of the Algerian Group of Extranodal Lymphomas (GALEG)
2016 · S Hamdi, I Bentahar, et al. · Blood · 2
Abstract 1003: Cascade genetic testing for hereditary cancer syndromes in Algerian population: pathways to precision medicine
2025 · Farid Cherbal, Chiraz Mehemmai, et al. · Cancer Research · 1
Securing Fluoropyrimidine-based chemotherapy: comparison of three methods of screening for dihydropyrimidine dehydrogenase deficiency.
2025 · F Bouchenak, N R Laoufi, et al. · PubMed · 1
Prospective evaluation of current RAS mutation testing practices in newly diagnosed metastatic colorectal cancer: Middle East and North Africa Registry (MORE-RAS) Study.
2020 · Mohammed Oukkal, Bouzid Kamel, et al. · Journal of Clinical Oncology · 1
A multicentre, international neoadjuvant (NA), randomized, double-blind phase III trial comparing fulvestrant to a combination of fulvestrant and palbociclib in patients with operable luminal breast cancer (SAFIA Trial)
2019 · J-MA Nabholtz, K.A. Alsaleh, et al. · Annals of Oncology · 1
Middle East & North Africa registry to characterize RAS mutation status and tumour specifications in recently diagnosed patients with metastatic colorectal cancer (MORE-RAS Study)
2019 · M. Oukkal, K. Bouzid, et al. · Annals of Oncology · 1
PDF
Gemcitabine (G) and cisplatin (C) in the treatment of locally advanced and/or metastatic pancreatic carcinoma
2001 · M. Oukkal, K. Bouzid, et al. · European Journal of Cancer · 1
Multidisciplinary team meeting in digestive cancers: a 6-year experience in an Algerian reference cancer center
2026 · Kamel Bentabak, Mohammed Oukkal, et al. · Pan African Medical Journal
Applicability of western guidelines in low and middle-income countries for locally advanced breast cancer: from “minimal requirements” to optimal management in 2025
2026 · Yazid Belkacemi, Kamel Debbi, et al. · Reports of Practical Oncology & Radiotherapy
PDF
Abstract 6273: Clinicopathological and genetic features of Algerian patients with suspected Li-Fraumeni Syndrome: Implications in genetic screening and testing.
2026 · Farid Cherbal, Chiraz Mehemmai, et al. · Cancer Research
Abstract PS2-02-18: Real-world epidemiologic and biological characterisation of breast cancer in Algeria: A multicenter real world data study on 6044 patients
2026 · A. Bounedjar, M. A. Melzi, et al. · Clinical Cancer Research
Métastase pancréatique d’un carcinome rénal à cellules claires : A propos d’un cas.
2025 · D Belabdi, H Fizi, et al. · Avicenna Medical Research
Works count: 35
Citation count: 96
H-index: 5
I10-index: 3
Year
Topic
Type